These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6213379)

  • 21. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic effectiveness of clindamycin phosphate (1% solution) compared with tetracycline (solution) administered topically in the treatment of acne vulgaris].
    Bran EL; Robledo Aguilar A
    Med Cutan Ibero Lat Am; 1986; 14(6):433-42. PubMed ID: 2951570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
    Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
    J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris.
    Stoughton RB; Cornell RC; Gange RW; Walter JF
    Cutis; 1980 Oct; 26(4):424-5, 429. PubMed ID: 6448131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical clindamycin therapy for acne vulgaris. A cooperative clinical study.
    Becker LE; Bergstresser PR; Whiting DA; Clendenning WE; Dobson RL; Jordan WP; Abell E; LeZotte LA; Pochi PE; Shupack JL; Sigafoes RB; Stoughton RB; Voorhees JJ
    Arch Dermatol; 1981 Aug; 117(8):482-5. PubMed ID: 6455095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.
    Pazoki-Toroudi H; Nilforoushzadeh MA; Ajami M; Jaffary F; Aboutaleb N; Nassiri-Kashani M; Firooz A
    Cutan Ocul Toxicol; 2011 Dec; 30(4):286-91. PubMed ID: 21612319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice.
    Korting HC; Braun-Falco O
    Drugs Exp Clin Res; 1989; 15(9):447-51. PubMed ID: 2534292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
    Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
    Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
    Gold MH; Rao J; Goldman MP; Bridges TM; Bradshaw VL; Boring MM; Guider AN
    J Drugs Dermatol; 2005; 4(1):64-70. PubMed ID: 15696987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BEST study: results according to prior treatment.
    Rodriguez D; Davis MW
    Cutis; 2003 Feb; 71(2 Suppl):27-34. PubMed ID: 12630672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Sheehan-Dare R; Layton A
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):311-9. PubMed ID: 17309451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical erythromycin vs blank vehicle in a multiclinic acne study.
    Jones EL; Crumley AF
    Arch Dermatol; 1981 Sep; 117(9):551-3. PubMed ID: 6457568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meclosorb, a new topical antibiotic agent in the treatment of acne vulgaris: a double-blind clinical study.
    Hjorth N; Schmidt H; Thomsen K; Dela K
    Acta Derm Venereol; 1984; 64(4):354-7. PubMed ID: 6209900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%.
    Zhang JZ; Li LF; Tu YT; Zheng J
    J Dermatolog Treat; 2004 Dec; 15(6):372-8. PubMed ID: 15764049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.
    Khodaeiani E; Fouladi RF; Amirnia M; Saeidi M; Karimi ER
    Int J Dermatol; 2013 Aug; 52(8):999-1004. PubMed ID: 23786503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris.
    Alirezaï M; Gerlach B; Horvath A; Forsea D; Briantais P; Guyomar M
    Eur J Dermatol; 2005; 15(4):274-8. PubMed ID: 16048758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
    Callender VD
    J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.